Amanote Research

Amanote Research

    RegisterSign In

In Vitro Screening for Genetic Signatures Associated With Sensitivity to Targeted Cancer Therapeutics

Science-Business eXchange
doi 10.1038/scibx.2013.1330
Full Text
Open PDF
Abstract

Available in full text

Date

December 1, 2013

Authors

Unknown

Publisher

Springer Science and Business Media LLC


Related search

Cancer Targeted Therapeutics: From Molecules to Drug Delivery Vehicles

Journal of Controlled Release
Pharmaceutical Science
2015English

Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics

Journal of Ovarian Research
GynecologyOncologyObstetrics
2010English

Bone Marrow Endothelium-Targeted Therapeutics for Metastatic Breast Cancer

Journal of Controlled Release
Pharmaceutical Science
2014English

Drug Screening to Target Nuclear Orphan Receptor NR4A2 for Cancer Therapeutics

Translational Lung Cancer Research
Oncology
2017English

Targeted Therapeutics

Cell
BiochemistryGeneticsMolecular Biology
2011English

CRADA Final Report: ErbB2 Targeted Cancer Therapeutics

2002English

Nanoparticle-Based Targeted Therapeutics in Head-And-Neck Cancer

International Journal of Medical Sciences
Medicine
2015English

Remaining Challenges in Childhood Cancer and Newer Targeted Therapeutics

Pediatric Clinics of North America
Child HealthPediatricsPerinatology
2015English

Novel Targeted Therapeutics for MEN2

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy